BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 11493458)

  • 1. Tumor necrosis factor-alpha induces coordinated changes in major histocompatibility class I presentation pathway, resulting in increased stability of class I complexes at the cell surface.
    Hallermalm K; Seki K; Wei C; Castelli C; Rivoltini L; Kiessling R; Levitskaya J
    Blood; 2001 Aug; 98(4):1108-15. PubMed ID: 11493458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28.
    van Hall T ; Sijts A; Camps M; Offringa R; Melief C; Kloetzel PM; Ossendorp F
    J Exp Med; 2000 Aug; 192(4):483-94. PubMed ID: 10952718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells.
    Khan AN; Gregorie CJ; Tomasi TB
    Cancer Immunol Immunother; 2008 May; 57(5):647-54. PubMed ID: 18046553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the MHC class I antigen presentation machinery in human embryonal carcinomas: evidence for deficiencies in TAP, LMP and MHC class I expression and their upregulation by IFN-gamma.
    Seliger B; Dunn T; Schwenzer A; Casper J; Huber C; Schmoll HJ
    Scand J Immunol; 1997 Dec; 46(6):625-32. PubMed ID: 9420627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bipartite regulation of different components of the MHC class I antigen-processing machinery during dendritic cell maturation.
    Li J; Schuler-Thurner B; Schuler G; Huber C; Seliger B
    Int Immunol; 2001 Dec; 13(12):1515-23. PubMed ID: 11717192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional deficiencies of components of the MHC class I antigen pathway in human tumors of epithelial origin.
    Delp K; Momburg F; Hilmes C; Huber C; Seliger B
    Bone Marrow Transplant; 2000 May; 25 Suppl 2():S88-95. PubMed ID: 10933198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markedly decreased expression of TAP1 and LMP2 genes in HLA class I-deficient human tumor cell lines.
    Singal DP; Ye M; Ni J; Snider DP
    Immunol Lett; 1996 May; 50(3):149-54. PubMed ID: 8803612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-beta mediates coordinate expression of antigen-processing genes in RSV-infected pulmonary epithelial cells.
    Jamaluddin M; Wang S; Garofalo RP; Elliott T; Casola A; Baron S; Brasier AR
    Am J Physiol Lung Cell Mol Physiol; 2001 Feb; 280(2):L248-57. PubMed ID: 11159003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC class I-deficient metastatic tumor variants immunoselected by T lymphocytes originate from the coordinated downregulation of APM components.
    Garcia-Lora A; Martinez M; Algarra I; Gaforio JJ; Garrido F
    Int J Cancer; 2003 Sep; 106(4):521-527. PubMed ID: 12845647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines.
    Brossart P; Bevan MJ
    Blood; 1997 Aug; 90(4):1594-9. PubMed ID: 9269778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of MHC class I, TAP1/2, and LMP2/7 gene in human gastric cancer cell lines.
    Kang JK; Yoon SJ; Kim NK; Heo DS
    Int J Oncol; 2000 Jun; 16(6):1159-63. PubMed ID: 10811990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired expression of proteasome subunits and human leukocyte antigens class I in human colon cancer cells.
    Miyagi T; Tatsumi T; Takehara T; Kanto T; Kuzushita N; Sugimoto Y; Jinushi M; Kasahara A; Sasaki Y; Hori M; Hayashi N
    J Gastroenterol Hepatol; 2003 Jan; 18(1):32-40. PubMed ID: 12519221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LMP2+ proteasomes are required for the presentation of specific antigens to cytotoxic T lymphocytes.
    Sibille C; Gould KG; Willard-Gallo K; Thomson S; Rivett AJ; Powis S; Butcher GW; De Baetselier P
    Curr Biol; 1995 Aug; 5(8):923-30. PubMed ID: 7583150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization.
    Regnault A; Lankar D; Lacabanne V; Rodriguez A; Théry C; Rescigno M; Saito T; Verbeek S; Bonnerot C; Ricciardi-Castagnoli P; Amigorena S
    J Exp Med; 1999 Jan; 189(2):371-80. PubMed ID: 9892619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of the transporter for antigen presentation, proteasome subunits, and class I major histocompatibility complex in tumor cell lines.
    Johnsen A; France J; Sy MS; Harding CV
    Cancer Res; 1998 Aug; 58(16):3660-7. PubMed ID: 9721876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presentation of viral antigens restricted by H-2Kb, Db or Kd in proteasome subunit LMP2- and LMP7-deficient cells.
    Zhou X; Momburg F; Liu T; Abdel Motal UM; Jondal M; Hämmerling GJ; Ljunggren HG
    Eur J Immunol; 1994 Aug; 24(8):1863-8. PubMed ID: 8056044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic T lymphocyte epitopes of HIV-1 Nef: Generation of multiple definitive major histocompatibility complex class I ligands by proteasomes.
    Lucchiari-Hartz M; van Endert PM; Lauvau G; Maier R; Meyerhans A; Mann D; Eichmann K; Niedermann G
    J Exp Med; 2000 Jan; 191(2):239-52. PubMed ID: 10637269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteasome subunits encoded in the MHC are not generally required for the processing of peptides bound by MHC class I molecules.
    Arnold D; Driscoll J; Androlewicz M; Hughes E; Cresswell P; Spies T
    Nature; 1992 Nov; 360(6400):171-4. PubMed ID: 1436094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of tapasin and immunoproteasome subunits in adenovirus type 5- versus type 12-transformed cells.
    Vertegaal AC; Kuiperij HB; Houweling A; Verlaan M; van der Eb AJ; Zantema A
    J Biol Chem; 2003 Jan; 278(1):139-46. PubMed ID: 12407112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of human cancers deficient in antigen processing.
    Restifo NP; Esquivel F; Kawakami Y; Yewdell JW; Mulé JJ; Rosenberg SA; Bennink JR
    J Exp Med; 1993 Feb; 177(2):265-72. PubMed ID: 8426105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.